MaxQ AI’s mission is to reinvent patient diagnosis through artificial intelligence (AI), improved triaging and diagnostics processes, and reduction of avoidable medical errors and costs —all leading to better patient outcomes.
Stroke and head trauma are two areas where we have initially focused. The statistics are staggering. Stroke is the second leading cause of death globally* and the number three cause of disability*. The cost of a missed brain bleed can be $150,000 per year patient*. But, the economic cost of treating a misdiagnosed patient is nothing compared to the devastation to the families.
Our complete ACCIPIO intracranial hemorrhage (ICH) suite is designed to potentially enhance clinical confidence, including mobilization of ischemic stroke and neurosurgery teams for mechanical clot removal. For example, in one industry study increased confidence in no-bleed confirmation increases the appropriate use of tPA by up to 73 percent*. MaxQ AI’s solutions are well-suited to help acute care physicians, who are under extreme pressure to make quick and accurate decisions while treating a large number of patients, reach faster, more accurate decisions when diagnosing stroke, head trauma, and other life-threatening conditions.